Rockville, MD. – December 12, 2014 – Clarassance, a privately held clinical-stage biotechnology company based in Maryland, today announced its new name: Therabron Therapeutics, Inc, which will serve it well as it moves forward in developing products to provide long-term improvement in  a wide range of respiratory diseases. Click here for more information.